Visitors
CN 93 IT 22 US 17 RU 7 BR 7 CH 4 CA 4 DE 4 NG 2 NL 2 BE 2 JP 2 GB 2 SG 2 IN 1 IL 1 QA 1 SA 1

国际尿石症联盟

Home > IAU Member

    Keqin Zhang

    • CountryChina
    1. Detailed Informations

    Keqin Zhang is the director of the Department of Urology, Daping hospital, affiliated to the third military medical university, Ph.D. Prof. Zhang achieved much outstanding and continuous work in improve the quality of kidney transplantation and development of cancer vaccines. His research funds is up to RMB $ 3 million. Some outstanding achievements had been awarded the first prize of Chongqing Science Technology Progress in 2010, the second prize of Chongqing Science and Technology Progress in 2007 and some other rewards. In recent decades, Prof. Zhang has published 30 original articles and 7 books.

    Education

    2006-2007: Postdoctoral Fellow,immunity,the university of Manitoba , Canadian

    1999-2002:M.D, Ph.D. Department of Urology, Third Military Medical University, China

    1993-1996:M.Sc. Institute of Kidney Disease, the center of kidney transplantation, General Hospital of Nanjing Military Distinct, China

    1984-1989,:B.Sc. Department of Military Medicine, Third Military Medical University, China

     

    Work experience:

    1989-1993Resident physician.Department of Nephrology,xinan hospital , Third Military Medical University, China

    1996-1999Attending doctor,Department of urology, the military general hospital of beijing PLA.china

    2002-2006: Attending doctor. Department of urology ,daping hospital , Third Military

    Medical University, China.

    2007--:  Assistant Professor. Daping hospital , Third Military Medical University, China.

    2010-2012Vice Director. Daping hospital , Third Military Medical University, China.

    2012--Director. Daping hospital , Third Military Medical University, China.

     

    Awards:

    1.     Foundation and clinical research in quality improve of kidney transplantation. The first prize of Research  Award of chongqing.2010,NO.1

    2.    The Research of molecular mechanism and prevention in bladder cancer recurrence. The second prize of Research  Award of chongqing.2007,NO.2

    3.    The improvement and clinical application in urology laparoscopic surgery technology. The second prize of clinical research of Military.2012,NO.8

    4.    The building of diagnostic criteria for classification and treatment programs of Urinary fistula after renal transplantation. The second prize of clinical research of Military.2010,NO.6

    5.    preventing in surgical complications after renal transplantation .The second prize of clinical research of Military.2007,NO.5

    6.     the state invention patent: (patent number: ZL01128928.7) 2002, NO.2

    7.     the state invention patent: (patent number: ZL200910104639.2) 2009,NO.6

    8.     the state invention patent:patent number: ZL201110228380.02013,NO.1

    9.     the national utility models patent (patent number: ZL201120182287.6) 2011, NO.3

    10.  the national utility models patent (patent number: ZL201120275893.2) 2011, NO.2

    11.  the national utility models patent (patent number: ZL201120275870.1) 2011, NO.2

    12.  the national utility models patent (patent number: ZL201120275904.7) 2011, NO.2

    13.  the national utility models patent (patent number: ZL201120259502.8) 2011, NO.2

    14.  the national utility models patent (patent number: ZL201120295226.0) 2011, NO.3

    15.  the national utility models patent (patent number: ZL201120440767.8) 2011, NO.2

    16.  the national utility models patent (patent number: ZL201120440775.2) 2011, NO.2

    17.  the national utility models patent (patent number: ZL201120394778.7) 2011, NO.2

    18.  the national utility models patent (patent number: ZL201120394782.3) 2011, NO.2

    19.  the national utility models patent (patent number:ZL201020134508.8) 2010, NO.4

    20.  the national utility models patent (patent number:ZL200920128506.5) 2009, NO.6

    21.  The national utility models patent(patent number:ZL200920128505.0) 2009 ,NO.6

    22.  The national utility models patent(patent number:ZL200720188318.2) 2007, NO.2

    23.  The national utility models patent(patent number: ZL01247783.4) 2002,NO.2.

     

    Publications:

    1.     Zhao-hui CaoWei-dong YinQuan-you Zheng,Shao-long FengGui-lian Xu, Ke-qin ZhangCorrespondence.Caspase-3 is Involved in IFN-c- and TNF-a-Mediated MIN6 Cells Apoptosis via NF-jB/Bcl-2 Pathway. Cell Biochem Biophys. 2013 Dec;67(3):1239-48. (IF:1.912)

    2.     Ke-qin Zhang1, Fei Yang, Jin Ye, Man Jiang, Yong Liu, Feng-shuo Jin, and Yu-zhang Wu.A Novel DNA/Peptide Combined Vaccine Induces PSCA-specific Cytotoxic T-lymphocyte Responses and Suppresses Tumor Growth in Experimental Prostate Cancer. Urology. 2012, 79(6): p1411IF2.428.

    3.     Keqin  Zhang1, Wenqian Huo,Rongrong Liu,Zhilin Nie,Jin Ye,Qiansheng Li .Diagnosis and treatment of hyper-delayed graft function after renal transplantation. Urol Int. 2012, 88(3):326-32IF1.065.

    4.     Gui-lian Xu1. Ke-qin Zhang1. BoGuoa. Ting-ting Zhao. Fei Yang. Man Jiang. Qing-hong Wang. Yu-hang Shang. Yu-zhang.Wu.aInduction of protective and therapeutic antitumor immunity by a DNA vaccine with Csd as molecular adjuvantvaccine28(2010)7221-7227IF3.616

    5.     Keqin Zhang.Lianyu Shan.Muhammad Sahidu Rahman.Helmut Unruh.Andrew J. Halayko.Abdelilah Soussi Gounni.Constitutive and Inducible Thymic Stromal Lymphopoietin Expression in Human Airway Smooth Muscle cells. American journal of Physiology, 2007 Aug; 293(2):375-82,(IF4.702)

    6.     Qiansheng Li.Chengguo Ge.Rongrong Liu. Keqin Zhang. GangWua.Wenqian Huo.Administration of dendritic cells dual expressing DcR3 and GAD65 mediates the suppression of T cells and induces long-term acceptance of pancreatic-islet transplantationvaccine28(2010)8300-8305(IF3.636).

    7.     Z.L. Nie,K.Q. Zhang,Q.S. Li,F.S. Jin,F.Q. Zhu,W.Q. Huo.Urological Complications in 1,223 Kidney TransplantationsUrologia internationalisUrol Int 2009;83:337–341(IF0.891)

    8.     Wenqian Huo, Keqin Zhang, Zhilin Nie, Qiansheng Li, Fengshuo JinKidney injury molecule-1 (KIM-1): a novel kidney-specific injury molecule playing potential double-edged functions in kidney injuryTransplantation Reviews 24 (2010) 143–146(IF1.60).

    9.     Z.-L. Nie, K.-Q. Zhang, Q.-S. Li, F.-S. Jin, F.-Q. Zhu, and W.-Q. Huo.Treatment of Urinary fistula after kidney transplentionTransplantation Proceedings, 41, 1624–1626 (2009)(IF1.055).

    10.  Pei-he Liang . Ke-qin Zhang .Gui-lian Xu.Yan-feng Li .Luo-fu Wang.Zhi-lin Nie.Jin Ye.Gang Wu.Cheng-guo Ge.Feng-shuo Jin.Construction of a DNA vaccine encoding Flk-1 extracellular  domain and C3d fusion gene and investigation of its suppressing  eVect on tumor growthCancer Immunol Immunother DOI 10.1007/s00262-009-0727-2(IF3.08);

    11.  Nie Z, Zhang KQ, Huo W, Li Q, Zhu F, Jin FComparison of urological complications with primary ureteroureterostomy versus conventional ureteroneocystostomy. Clin Transplant 2009 DOI: 10.1111/j.1399-0012.2009.01134.(IF1.915)

     

    Research

    1.     Construction and clinical research of tissue engineering of the urethra. The Key Program of National Programs of Chongqing, 2012-2015,NO.1, RMB¥ 1,000,000.

    2.     The molecular mechanisms of C5aR promoting the expression of Fgl2 in renal ischemia-reperfusion injury. The General Program of National Natural Science Foundation of China, 2014-2017, NO.1, RMB¥ 700,000.

    3.     Regulation of complement C3 in Th17 during renal allograft rejection. The General Program of National Natural Science Foundation of China, 2012-2015, NO.1, RMB¥ 580,000.

    4.     Research on construction and effect of PSCA peptide-DNA particle composite vaccine. The General Program of National Natural Science Foundation of China, 2008-2011, NO.1, RMB¥ 300,000.

    5.     Research on construction and effect of FLK1-C3d vaccines which targeting tumor vasculature. The General Program of National Natural Science Foundation of China, 2006-2008, NO.2, RMB¥ 278,000.

    6.     Construction and study of a new vaccine for prostate cancer. The General Program of Natural Science Foundation of Chongqing,2007-2010,NO.1, RMB¥ 30,000.

    7.     Development and application of artificial intelligence bladder. The basic research projects of Chongqing. 2000-2002, NO.1, RMB¥ 100,000.

    8.     To build the PSCA-DNA vaccine. Scientific Research Starting Foundation for the Returned Overseas Chinese Scholars, The Third Military Medical University.2007-2009, NO.1, RMB¥ 50,000.

    9.     The early diagnosis of Acute renal allograft dysfunction. Clinical Research Fund,  The Third Military Medical University. 2008-2010, NO.1, RMB¥ 50,000.


    Powered by MetInfo 5.3.17 ©2008-2018